Clinical Cancer Research CR Helping Patients AACR Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Santini, D.
Right arrow Articles by Picciocchi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santini, D.
Right arrow Articles by Picciocchi, A.
Clinical Cancer Research Vol. 11, 3784-3789, May 15, 2005
© 2005 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Cyclooxygenase-2 Overexpression Is Associated with a Poor Outcome in Resected Ampullary Cancer Patients

Daniele Santini1, Bruno Vincenzi1, Giuseppe Tonini1, Susanna Scarpa2, Fortunata Vasaturo2, Carolina Malacrino2, Fabio Vecchio3, Domenico Borzomati1, Sergio Valeri1, Roberto Coppola1, Paolo Magistrelli3, Gennaro Nuzzo3 and Aurelio Picciocchi3

Authors' Affiliations: 1 University Campus Bio-Medico; 2 Department of Experimental Medicine and Pathology, University "La Sapienza"; and 3 Catholic University of the Sacred Heart, Rome, Italy

Requests for reprints: Giuseppe Tonini, Campus Bio-Medico University, Via Emilio Longoni, 83, 00155 Rome, Italy. Phone: 39-06-22541853; Fax: 39-06-22541520; E-mail: g.tonini{at}unicampus.it.

Purpose: To identify potential prognostic molecular factors in ampullary adenocarcinoma that could be of significant importance. To this end, we examined the possible prognostic significance of cyclooxygenase-2 (Cox-2) and Survivin expression and the apoptotic index in a cohort of uniformly treated patients with ampullary cancer treated with radical surgical excision.

Experimental Design: The entry criteria were that the patients have a pathologic diagnosis of ampullary cancer which had been resected. Expression analysis for Cox-2 and Survivin was done by immunohistochemical staining. Apoptotic cells were identified by the terminal deoxyribonucleotidyl transferase–mediated dUTP nick-end labeling (TUNEL) method.

Results: Thirty-nine tumor specimens from resected ampullary adenocarcinoma patients were included. By univariate analysis, overall survival was affected by Cox-2 expression and TUNEL staining (respectively, P = 0.0003 and 0.03). Survivin expression did not influence the overall survival in our patient population (P = 0.123). Patients' clinicopathologic features (gender, age, and T and N factors) did not influence outcome. In multivariate Cox regression analysis, Cox-2 expression (relative risk, 4.330; P = 0.005) was the only variable that significantly affected overall survival.

Conclusions: The results of the present article provide, for the first time, evidence that Cox-2 expression, but not Survivin expression, may represent a significant prognostic factor after surgical resection in patients affected by cancer of the ampulla of Vater. Further studies are required to determine whether Cox-2 inhibitors may be useful for the therapy or prevention of ampullary carcinoma.

Key Words: cancer of the ampulla • Cox-2 • Survivin • apoptosis • survival




This article has been cited by other articles:


Home page
Ann OncolHome page
B. Vincenzi, D. Santini, G. Perrone, A. Russo, V. Adamo, S. Rizzo, F. Castri, A. Antinori, R. Alloni, P. F. Crucitti, et al.
Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients
Ann. Onc., January 1, 2009; 20(1): 78 - 83.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.